Surprisingly, levels of DMT1 and TfR decreased following CKD development, were reduced by CDDP intervention, and were significantly restored after treatment with DFO (Fig. 4a, c, and d), suggesting that, DFO, unlike CDDP, can facilitate restoration of iron homeostasis. This evidence concerns the gene SLC11A2 and chronic kidney disease.